Severe ethylene glycol poisoning treated with fomepizole (4-methylpyrazole);Alvorlig etylenglykolforgiftning behandlet med fomepizol (4-metylpyrazol)

Tidsskrift for den Norske Laegeforening

Volumn 122, Issue 25, 2002, Pages 2444-2446

  Aakervik, Odd ^a   Svendsen, Jan ^a   Jacobsen, Dag ^a  

^a Medisinsk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHYLPYRAZOLE; ALCOHOL; ALCOHOL DEHYDROGENASE; BICARBONATE; CHLORPROTHIXENE; ETHYLENE GLYCOL; SERTRALINE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HEMODIALYSIS; HUMAN; INTOXICATION; KIDNEY FAILURE; MALE; METABOLIC ACIDOSIS; METHANOL POISONING; TREATMENT OUTCOME;

ADULT; ANTIDOTES; ETHYLENE GLYCOL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; POISONING; PYRAZOLES;

EID: 0037145440     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jacobsen D, McMartin KE. Antidotes for methanol and ethylene glycol poisoning. J Toxicol Clin Toxicol 1997; 35: 127-43.
2. Watson WA. Ethylene glycol toxicity: Closing on rational, evidence-based treatment. Ann Emerg Med 2000; 36: 139-41.
3. Persson H. Forgiftning med etylenglykol och metanol. Fomepizol - en alternativ antidot. Läkartidningen 2001; 98: 3334-7.
4. Aabakken L, Enger E, Jacobsen D, Strømme JH. Metabolsk acidose - en diagnostisk utfordring. Tidsskr Nor Lægeforen 1994; 114: 331-4.
5. Brent J, McMartin K, Phillips S, Burkhart KK, Donovan W, Wells M. Fomepizole for the treatment of ethylene glycol poisoning. N Engl J Med 1999; 340: 832-8.
6. Jacobsen D. New treatment for ethylene glycol poisoning. N Engl J Med 1999; 340: 879-81.
7. Kowalczyk M, Halvorsen S, Øvrebø S, Jacobsen D. Ethanol therapy in ethylene glycol poisoned patients. Vet Hum Toxicol 1998; 40: 225-8.
8. Li TK, Theorell H. Human liver alcohol dehydrogenase inhibition by pyrazole and pyrazol analogs. Acta Chemi Scand 1969; 23: 892-902.
9. Blomstrand R, Theorell H. Inhibitory effect of ethanol oxidation in man after administration of 4-methylpyrazol. Life Sciences 1970; 9: 631-40.
10. McMartin KE, Hedstrøm KG, Tolf BR, Østling-Wintzell H, Blomstrand R. Studies on the metabolic interactions between 4-methylpyrazole and methanol using the monkey as an animal model. Arch Biochem Biophys 1980; 199: 606-14.
11. Baud FJ, Galliot M, Astier A, Bien DV, Garnier R, Likforman J et al. Treatment of ethylene glycol poisoning with intravenous 4-methylpyrazole. N Engl J Med 1988; 319: 97-100.
12. Jacobsen D, Sebastian CS, Blomstrand R, McMartin KE. 4-Methylpyrazole: A controlled study of safety in healthy human subjects after single, ascending doses. Alcohol Clin Exp Res 1988; 12: 516-22.
13. Jacobsen D, Sebastian CS, Barron SK, Carriere EW, McMartin KE. Effects of 4-methylpyrazole, methanol/ethylene glycol antidote, in healthy humans. J Emerg Med 1990; 8: 455-61.
14. Brent J, McMartin K, Phillips S, Aaron C, Kulig K. Fomepizole for the treatment of methanol poisoning. N Engl J Med 2001; 344: 424-9.
15. Sivilotti MLA, Burns M, McMartin KE, Brent J. Toxicokinetics of ethylene glycol during fomepizol therapy: Implications for management. Ann Emerg Med 2000; 36: 114-25.
16. Solheim L, Andrew E, Jacobsen D. Antidotberedskap i norge. Tidsskr Nor Lægeforen 2002, 122: 1111-3.